Design of lonzymes for prodrug-based cancer therapy

Detalhes bibliográficos
Autor(a) principal: Russo, André
Data de Publicação: 2022
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/143742
Resumo: Cancer is one of the major public health issues in the world, being one of the principal causes of death around the world. Different cancer treatments have been extensively studied in the past years, being nanomedicine one of the latest approaches with tremendous potential, studied by various research groups for cancer therapy. Different types of nanoparticles can be used for different methods, and have different properties. Some of the different types of na-noparticles being studied for cancer treatment are inorganic nanoparticles, organic nanopar-ticles, polymeric nanoparticles like chitosan nanoparticles and iron oxide nanoparticles. In this work, we have evaluated the peroxidase-like activity of iron oxide nanoparticles to convert paracetamol to its` cytotoxic form, in order to kill cancer cells. And in order to use the peroxidase-like activity of iron oxide nanoparticles with paracetamol, we incorporated the prodrug and the iron oxide nanoparticles by coating them with chitosan using the ionotropic gelation technique. After we optimized the encapsulation process and achieved homogeneous suspensions of nanoparticles coated with chitosan and with 55% of encapsulation efficiency of the drug, the obtained nanoparticles were characterized in terms of their constitution and cytotoxicity. The characterization results confirmed the presence of paracetamol in the ob-tained nanoparticles, and that the incorporation of paracetamol didn`t significantly change the physical and chemical properties of iron oxide nanoparticles coated with chitosan. The cytotoxicity results showed no significant cytotoxicity of nanoparticles with paracetamol when compared with nanoparticles without paracetamol, leading us to conclude that parace-tamol was either not converted to its cytotoxic form by peroxidase-like activity, or was not converted to the extent required for a cytotoxic effect.
id RCAP_4b7efa0dc173c16db13faa47b3627333
oai_identifier_str oai:run.unl.pt:10362/143742
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Design of lonzymes for prodrug-based cancer therapyiron oxide nanoparticlesparacetamolperoxidase-like activitychitosanionotropic gelationDomínio/Área Científica::Engenharia e Tecnologia::NanotecnologiaCancer is one of the major public health issues in the world, being one of the principal causes of death around the world. Different cancer treatments have been extensively studied in the past years, being nanomedicine one of the latest approaches with tremendous potential, studied by various research groups for cancer therapy. Different types of nanoparticles can be used for different methods, and have different properties. Some of the different types of na-noparticles being studied for cancer treatment are inorganic nanoparticles, organic nanopar-ticles, polymeric nanoparticles like chitosan nanoparticles and iron oxide nanoparticles. In this work, we have evaluated the peroxidase-like activity of iron oxide nanoparticles to convert paracetamol to its` cytotoxic form, in order to kill cancer cells. And in order to use the peroxidase-like activity of iron oxide nanoparticles with paracetamol, we incorporated the prodrug and the iron oxide nanoparticles by coating them with chitosan using the ionotropic gelation technique. After we optimized the encapsulation process and achieved homogeneous suspensions of nanoparticles coated with chitosan and with 55% of encapsulation efficiency of the drug, the obtained nanoparticles were characterized in terms of their constitution and cytotoxicity. The characterization results confirmed the presence of paracetamol in the ob-tained nanoparticles, and that the incorporation of paracetamol didn`t significantly change the physical and chemical properties of iron oxide nanoparticles coated with chitosan. The cytotoxicity results showed no significant cytotoxicity of nanoparticles with paracetamol when compared with nanoparticles without paracetamol, leading us to conclude that parace-tamol was either not converted to its cytotoxic form by peroxidase-like activity, or was not converted to the extent required for a cytotoxic effect.O cancro é um dos maiores problemas de saúde pública no mundo, sendo uma das principais causas de morte no mundo inteiro. Diferentes tratamentos para o cancro têm sido extensivamente estudados nos últimos anos, sendo a nanomedicina uma das mais recentes abordagens com um tremendo potencial a ser estudada por vários grupos para o tratamento do cancro. Diferentes tipos de nanopartículas podem ser usadas no tratamento do cancro, em diferentes métodos e com diferentes propriedades. Algumas das diferentes nanopartículas a serem estudadas para o tratamento do cancro são as nanopartículas inorgânicas, nanopartí-culas orgânicas, nanopartículas poliméricas como por exemplo nanopartículas de quitosano, e nanopartículas de óxido de ferro. Neste trabalho, tentámos avaliar a atividade de peroxidase das nanopartículas de óxido de ferro para converter paracetamol na sua forma citotóxica, de forma a poder matar células cancerígenas. E de modo a usar a atividade de peroxidase das nanopartículas de óxido de ferro com o paracetamol, incorporámos as nanopartículas e o fármaco ao revesti-los com qui-tosano usando a técnica de gelação ionotrópica. Depois de obtermos suspensões homogéneas de nanopartículas revestidas com quitosano e com uma eficiência de encapsulação de 55% do fármaco, caraterizámo-las em termos da sua constituição e citotoxicidade. Os resultados da caraterização confirmaram a presença de paracetamol nas nanopartículas obtidas, e que a in-corporação de paracetamol não alterou de forma significativa as propriedades físicas e quími-cas das nanopartículas de óxido de ferro encapsuladas com quitosano. Os resultados de cito-toxicidade não apresentaram citotoxicidade significativa por parte das nanopartículas com paracetamol quando comparadas com nanopartículas sem paracetamol, levando-nos a con-cluir que não houve conversão do paracetamol na sua forma citotóxica por atividade da pe-roxidase.Borges, JoãoBarreiros, SusanaRUNRusso, André2022-09-15T12:07:01Z2022-022022-02-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/143742enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:22:27Zoai:run.unl.pt:10362/143742Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:51:07.423659Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Design of lonzymes for prodrug-based cancer therapy
title Design of lonzymes for prodrug-based cancer therapy
spellingShingle Design of lonzymes for prodrug-based cancer therapy
Russo, André
iron oxide nanoparticles
paracetamol
peroxidase-like activity
chitosan
ionotropic gelation
Domínio/Área Científica::Engenharia e Tecnologia::Nanotecnologia
title_short Design of lonzymes for prodrug-based cancer therapy
title_full Design of lonzymes for prodrug-based cancer therapy
title_fullStr Design of lonzymes for prodrug-based cancer therapy
title_full_unstemmed Design of lonzymes for prodrug-based cancer therapy
title_sort Design of lonzymes for prodrug-based cancer therapy
author Russo, André
author_facet Russo, André
author_role author
dc.contributor.none.fl_str_mv Borges, João
Barreiros, Susana
RUN
dc.contributor.author.fl_str_mv Russo, André
dc.subject.por.fl_str_mv iron oxide nanoparticles
paracetamol
peroxidase-like activity
chitosan
ionotropic gelation
Domínio/Área Científica::Engenharia e Tecnologia::Nanotecnologia
topic iron oxide nanoparticles
paracetamol
peroxidase-like activity
chitosan
ionotropic gelation
Domínio/Área Científica::Engenharia e Tecnologia::Nanotecnologia
description Cancer is one of the major public health issues in the world, being one of the principal causes of death around the world. Different cancer treatments have been extensively studied in the past years, being nanomedicine one of the latest approaches with tremendous potential, studied by various research groups for cancer therapy. Different types of nanoparticles can be used for different methods, and have different properties. Some of the different types of na-noparticles being studied for cancer treatment are inorganic nanoparticles, organic nanopar-ticles, polymeric nanoparticles like chitosan nanoparticles and iron oxide nanoparticles. In this work, we have evaluated the peroxidase-like activity of iron oxide nanoparticles to convert paracetamol to its` cytotoxic form, in order to kill cancer cells. And in order to use the peroxidase-like activity of iron oxide nanoparticles with paracetamol, we incorporated the prodrug and the iron oxide nanoparticles by coating them with chitosan using the ionotropic gelation technique. After we optimized the encapsulation process and achieved homogeneous suspensions of nanoparticles coated with chitosan and with 55% of encapsulation efficiency of the drug, the obtained nanoparticles were characterized in terms of their constitution and cytotoxicity. The characterization results confirmed the presence of paracetamol in the ob-tained nanoparticles, and that the incorporation of paracetamol didn`t significantly change the physical and chemical properties of iron oxide nanoparticles coated with chitosan. The cytotoxicity results showed no significant cytotoxicity of nanoparticles with paracetamol when compared with nanoparticles without paracetamol, leading us to conclude that parace-tamol was either not converted to its cytotoxic form by peroxidase-like activity, or was not converted to the extent required for a cytotoxic effect.
publishDate 2022
dc.date.none.fl_str_mv 2022-09-15T12:07:01Z
2022-02
2022-02-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/143742
url http://hdl.handle.net/10362/143742
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138106211827712